“driving with dementia”的搜索结果，显示 171-180 项，共有 472 项

1. 神经科- 临床试验- 妙佑医疗国际

   There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection is ...

2. 神经科- 临床试验- 妙佑医疗国际

   ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...

3. 日落综合征：晚间混乱

   ... Alzheimer's disease and related dementia. Frontiers in Neuroscience. 2020; doi:10.3389/fnins.2020.00910. Sleep issues and sundowning. Alzheimer's Association.

4. 神经科- 临床试验- 妙佑医疗国际

   There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection is ...

5. 轻度认知损害- 诊断与治疗- 妙佑医疗国际

   Cummings J, et al. Alzheimer's disease drug development pipeline: 2022. Alzheimer's and Dementia. 2022; doi:10.1002/trc2.12295. Memory, forgetfulness and ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to characterize the astrocyte response to various inflammatory drivers in the presence of innate immune cells collected from ...

7. 神经科- 临床试验- 妙佑医疗国际

   ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...

8. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to characterize the astrocyte response to various inflammatory drivers in the presence of innate immune cells collected from ...

9. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to characterize the astrocyte response to various inflammatory drivers in the presence of innate immune cells collected from ...

10. 神经科- 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to investigate whether recent, groundbreaking discoveries about key pathophysiologic processes that drive ...